tirzepatide news september 27 2025 Impact of the CVS GLP-1 formulary change: Trends in switching FDA Grants Tirzepatide a New

The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers

But the rash returns worse than before once the steroid is stopped, creating a frustrating cycle of temporary relief followed by rebound flaring

Cardiovascular protection: the benefit that saves lives Heart disease kills more people than any other condition on the planet

Complete details about these changes will be available by May 21, 2026 in the Whats New section

These effects allow patients to feel full sooner, manage insulin levels, and support both weight loss and metabolic health

Potential candidates may include: Women with menopausal symptoms